Percy is a visual testing platform that automates the detection of UI changes by capturing screenshots, comparing them against baselines, and highlighting visual differences. Integrated into CI/CD workflows, Percy supports cross-browser and responsive testing, enabling teams to identify visual regressions early in the development process. Its AI-powered visual engine reduces false positives and streamlines the review process, facilitating faster and more confident releases.
Status: Acquired
Abelian Therapeutics
Nascent biotech company harnessing emerging science on the importance of Glia in brain disease. Abelian Therapeutics was acquired in September 2020.
BlackDuck
BlackDuck secures and manages open source software worldwide, eliminating open source security vulnerabilities & license compliance pain. BlackDuck was acquired by Synopsys in 2017.
A Fidelity Ventures investment. Fidelity Ventures was a venture capital investment group affiliated with F-Prime until 2010.
mindSHIFT
mindSHIFT is one of the largest IT outsourcing and cloud services providers. The company has supported our clients with tailored and trusted technology solutions for more than 15 years. From day-to-day IT to major systems modernization, count on mindSHIFT’s technology expertise and personalized customer care for all of your IT needs. mindSHIFT was acquired by Roche Company in 2014.
A Fidelity Ventures investment. Fidelity Ventures was a venture capital investment group affiliated with F-Prime until 2010.
Modis Therapeutics
Modis Therapeutics, Inc. was formed in 2016 through a collaboration with academic experts in mitochondrial biology. The company’s lead program (MT1621) is in clinical development for thymidine kinase 2 deficiency (TK2d), an inherited mitochondrial disease. Modis Therapeutics is headquartered in Oakland CA, with offices in New York City. Modis was acquired by Zogenix.
Nebula Genomics
Nebula Genomics is a human genome sequencing and health big data company on a mission to usher in the era of genomic sequencing by building a large and trusted genomic and health data marketplace for consumers, researchers and the medical community. Using blockchain to ensure that consumers maintain control of their data and are compensated for its use, the Nebula marketplace will aggregate a critical mass of rich genetic information that researchers can analyze in order to accelerate drug development, streamline clinical trials, and usher in the era of truly personalized medicine. Nebula Genomics was acquired by ProPhase Labs in 2021.
Farapulse
Farapulse is a medical device company developing a novel approach to treating a range of arrhythmias using pulsed electric field. Farapulse was acquired by Boston Scientific in 2021.
Apellis Pharmaceuticals
Apellis Pharmaceuticals, Inc. (NASDAQ: APLS) is a clinical-stage biopharmaceutical company focused on the development of novel therapeutic compounds to treat disease through the inhibition of the complement system, at the level of C3, the central protein in the complement cascade. Acquired by Biogen in 2026.
Threat Stack
Threat Stack enables growth-driven companies to scale securely and meet complex cloud security needs by identifying and verifying insider threats, external attacks, and data loss in real time. With a comprehensive approach to intrusion detection, Threat Stack empowers security and operations to better manage risk and compliance across their entire infrastructure, including cloud, hybrid cloud, multi-cloud, and containerized environments. Threat Stack was acquired by F5 Networks in 2021.
Valor Performance
Valor Performance is the premier digital learning platform focused on sustaining performance for executives and sales leaders. Valor’s software platform delivers personalized and research-based exercises as well as dedicated Valor coaches, who integrate the latest research on stress management and burnout with the insights of world-class athletes. Valor Performance was acquired by Mursion in 2024.